McCullough Peter A, Stacul Fulvio, Becker Christoph R, Adam Andy, Lameire Norbert, Tumlin James A, Davidson Charles J
William Beaumont Hospital, Royal Oak, Michigan, USA.
Rev Cardiovasc Med. 2006 Fall;7(4):177-97.
With the advances made in radiology and cardiology, greater numbers of patients are expected to undergo exposure to iodinated contrast media in the years to come. Contrast-induced nephropathy (CIN) accounts for a significant number of cases of hospital-acquired renal failure, with adverse effects on prognosis and healthcare costs. The CIN Consensus Working Panel is an international multidisciplinary group convened to address the challenges of CIN. The group reviewed 865 published papers, chosen for potential relevance from a comprehensive literature search that identified over 4000 references. The results were used to compile reviews covering the epidemiology and pathogenesis of CIN, baseline renal function measurement, risk assessment, identification of high-risk patients, contrast medium use, and preventive strategies. In this executive summary, consensus statements and an algorithm for the risk stratification and management of CIN are presented.
随着放射学和心脏病学的发展，预计在未来几年会有更多患者接受碘化造影剂。造影剂肾病（CIN）占医院获得性肾衰竭的相当一部分病例，对预后和医疗费用有不良影响。CIN共识工作小组是一个国际多学科小组，旨在应对CIN带来的挑战。该小组审查了865篇已发表的论文，这些论文是从超过4000篇参考文献的全面文献检索中挑选出的具有潜在相关性的文献。研究结果被用于编写涵盖CIN的流行病学和发病机制、基线肾功能测量、风险评估、高危患者识别、造影剂使用及预防策略的综述。在本执行摘要中，给出了CIN风险分层和管理的共识声明及算法。
